Sponsor:
Benitec Biopharma, Inc.
Code:
NCT06185673
Conditions
Oculopharyngeal Muscular Dystrophy
Eligibility Criteria
Sex: All
Age: 0 - 65
Healthy Volunteers: Not accepted
Interventions
BB-301: Dose escalation phase 1b cohort 1
BB-301: Dose escalation phase 1b cohort 2
BB-301: Dose escalation phase 1b cohort 3
BB-301: Dose expansion phase 2a
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations